Medidata Launches New myMedidata Native App

The emerging solution helps assess how much a therapy being evaluated in a clinical trial can benefit an individual patient.

The top five episodes of our podcast in the year 2024, highlighted.

In the study, nipocalimab plus standard of care demonstrated superiority in activities of daily living for patients with generalized myasthenia gravis.

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.

Initial data from Phase I clinical trial showed encouraging single agent activity in patients with different types of PD-1 resistant tumors.

Study finds the typical cost of clinical research for developing new drugs is lower than previously estimated, with median costs providing a more accurate reflection than mean costs.